A multifactorial interdisciplinary intervention reduces frailty in older people: randomized trial by Ian D Cameron et al.
RESEARCH ARTICLE Open Access
A multifactorial interdisciplinary intervention
reduces frailty in older people: randomized trial
Ian D Cameron1*, Nicola Fairhall1,2, Colleen Langron3, Keri Lockwood1, Noeline Monaghan1, Christina Aggar4,
Catherine Sherrington2, Stephen R Lord5 and Susan E Kurrle3
Abstract
Background: Frailty is a well known and accepted term to clinicians working with older people. The study aim
was to determine whether an intervention could reduce frailty and improve mobility.
Methods: We conducted a single center, randomized, controlled trial among older people who were frail in
Sydney, Australia. One group received an intervention targeting the identified characteristics of frailty, whereas the
comparison group received the usual health care and support services. Outcomes were assessed by raters masked
to treatment allocation at 3 and 12 months after study entry. The primary outcomes were frailty as assessed by the
Cardiovascular Health Study criteria, and mobility as assessed by the Short Physical Performance Battery. Secondary
outcome measures included disability, depressive symptoms and health-related quality of life.
Results: A total of 216 participants (90%) completed the study. Overall, 68% of participants were women and the
mean age was 83.3 years (standard deviation, 5.9). In the intention-to-treat analysis, the between-group difference
in frailty was 14.7% at 12 months (95% confidence interval: 2.4%, 27.0%; P = 0.02). The score on the Short Physical
Performance Battery, in which higher scores indicate better physical status, was stable in the intervention group
and had declined in the control group; with the mean difference between groups being 1.44 (95% confidence
interval, 0.80, 2.07; P <0.001) at 12 months. There were no major differences between the groups with respect to
secondary outcomes. The few adverse events that occurred were exercise-associated musculoskeletal symptoms.
Conclusions: Frailty and mobility disability can be successfully treated using an interdisciplinary multifaceted
treatment program.
Trial registration: Australia and New Zealand Clinical Trials Register (ANZCTR): ACTRN12608000250336
Keywords: activities of daily living, frail elderly, randomized controlled trial, therapeutics, walking
Background
Frailty is a key theme in the aging literature, with
research to date allowing an increased understanding of
the definition, biological basis and associations of frailty
[1]. Care of frail individuals is hindered, however, by the
lack of clear consensus on how frailty should be assessed
and diagnosed in the clinical setting [2,3]. Furthermore,
frailty is usually comorbid with multiple medical condi-
tions. Vulnerability to deterioration can render care of
the frail person difficult, given the generally fragmented
and underfunded nature of current health delivery mod-
els, particularly in the community setting.
Two main definitions of frailty are currently accepted.
The Cardiovascular Health Study (CHS) Frailty Phenotype
[1] diagnoses people as frail if they meet pre-determined
values for three or more of five criteria: slow gait speed,
weak grip strength, exhaustion, low energy expenditure,
and weight loss. Alternatively, the use of a Frailty Index
can measure the deficits present in an individual as a pro-
portion of all potential deficits across multiple domains
(for example, chronic diseases, mood, social resources,
cognition) [4]. Other measures of frailty include using a
combination of instruments, each measuring a single
aspect of frailty [5].
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An increasing number of studies have defined the syn-
drome of frailty and measured its prevalence. Though
several intervention studies have also been conducted in
which frail older people have participated, few have
recruited participants based on a specific definition of
frailty [6]. Furthermore, to our knowledge, no interven-
tions have been developed to specifically reverse the
syndrome of frailty and there are no intervention studies
that have had frailty (specifically defined) as a primary
outcome. We propose that, by conducting a multifactor-
ial intervention targeting each component of frailty
shown to be amenable to modification in previous stu-
dies in frail older people, frailty can be reduced.
We sought to compare the effects of a multifactorial,
interdisciplinary intervention specifically targeting frailty
with usual care. The study aimed to establish the effects
of the intervention on both frailty and impaired mobility.
The hypotheses were that the multifactorial, interdisci-
plinary intervention would reduce frailty assessed with a
frailty phenotype score [1], improve mobility as measured
with the Short Physical Performance Battery (SPPB) [7],
and have a positive effect on a number of secondary out-
come measures including disability, depressive symptoms
and health-related quality of life.
Methods
Study design
We conducted a single center, randomized, controlled trial
among older people who were frail in Sydney, Australia.
The trial protocol has been previously reported [8].
The Northern Sydney & Central Coast Health Human
Research Ethics Committee has approved the study proto-
col - Research Protocol Number 0709-191M - and the
trial is registered with the Australian New Zealand Clinical
Trials Registry: ACTRN12608000250336. Trial registration
was delayed and 8% of the participants had been rando-
mized at the time of registration. Participants provided
written informed consent before randomization.
Study population, screening and randomization
Eligible participants were identified from older people
treated by clinicians working within the Division of Reha-
bilitation and Aged Care Services (DRACS) at Hornsby
Ku-ring-gai Health Service (Sydney, Australia). DRACS is
a large clinical service that has programs operating both in
the community and hospital settings. Eligible participants
first completed their usual treatment program before
being approached to enter the study. Following participa-
tion agreement, informed consent was sought, often in
conjunction with relatives. If granted, the study nurse
screened for inclusion criteria. These were: adults aged
70 years or older with three or more of the CHS frailty
criteria [1]; not usually living in a residential aged care
facility; residing in the Hornsby or Ku-ring-gai local
government areas; without moderate or severe cognitive
impairment (defined as a Mini Mental State Examination
score of ≤18) [9]; not an ongoing client of DRACS; with-
out an illness likely to be associated with a life expectancy
of <12 months, estimated by a score of ≤3 on a modified
version of the Implicit Illness Severity Scale [10]; and not
participating in another physical intervention research
project. All randomized participants met the eligibility
criteria.
Interventions
Participants in the intervention group received a multi-
factorial, interdisciplinary treatment program intended
to target frailty for a 12-month period following rando-
mization. The interventions were individually tailored to
each participant based on their frailty characteristics as
assessed at baseline, and additional problems as identi-
fied during a detailed assessment by the two experienced
physiotherapists providing the intervention program.
Geriatric evaluation and management principles under-
pinned both the assessment and intervention [11].
Details of the approach to intervention are described in
the protocol paper [8]. To summarize, the CHS frailty
components that were present in each participant were
specifically targeted [12]. If the participant met the weight
loss criterion, a dietician evaluated nutritional intake.
Home-delivered meals were recommended if appropriate
clinical criteria applied. In addition, if the participant’s
body mass index was <18.5 kg/m2, or mid-upper arm cir-
cumference was <the 10th percentile (using Australian age
and gender specific norms), nutritional supplementation
was offered using commercially available, high energy,
high protein supplements.
If the exhaustion criterion was met and the Geriatric
Depression Scale [13] score was high, the study team
considered referral to a psychiatrist or psychologist.
Where the participant was socially isolated, options to
encourage greater social engagement were identified,
such as participation in day activity groups and tele-
phone contact with a volunteer.
Participants who met the weakness, slowness or low
energy expenditure criteria received up to 10 home-based
physiotherapy sessions and performed a home exercise
program, over the course of 12 months. The Weight-bear-
ing for Better Balance (WEBB) program [14], designed to
improve mobility, increase physical activity and prevent
falls, was tailored to individual’s physical impairments, pre-
scribed three to five times per week, and reviewed regu-
larly. Two physiotherapy sessions targeted the participant’s
mobility goal. Equipment was also recommended as
necessary.
Case management by the physiotherapist, and regular
case conferences involving the physiotherapist, geriatri-
cian, rehabilitation physician, nurse and dietician,
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facilitated coordination of the delivery of the interven-
tion. Reassessment was ongoing throughout the inter-
vention phase. The physiotherapist was the co-ordinator
of the intervention. Home visits usually involved several
intervention components and included not only the
WEBB exercise program, but other identified interven-
tions that were relevant to the frail person at that parti-
cular time.
For all participants, additional interventions were then
provided or recommended based on a comprehensive
geriatric evaluation, for example review by the study
geriatrician or rehabilitation physician, follow-up of
chronic diseases, treatment of pain, and management of
other identified conditions such as urinary incontinence.
The major limiting factor in implementing the inter-
vention as planned was the limited ability of the partici-
pants to be able to adhere with the recommended
intervention plan. The physiotherapists coordinating the
intervention were careful not to overwhelm the partici-
pants with complex treatment plans and, in addition,
participants often declined specific interventions.
There was a standardized approach to interventions in
the study based on the study protocol and regular case
discussions of each participant. The physiotherapist pri-
marily responsible for each participant documented
adherence to the study protocol and estimated a global
level of adherence (in five categories) over the 12-month
intervention period.
Usual care, as received by the control group in this
study, consisted of those health and aged care services
that would normally be available to older people. These
include general practitioner and medical specialist con-
sultations, and nursing and allied health interventions as
appropriate. Australia has a system of universal health
insurance so that all of its population has access to
health care without significant cost. Aged care services
include assistance with housekeeping and personal care
and these types of services are also heavily subsidized by
the Australian government for older people with care
needs. Northern Sydney has a well-developed system of
health and aged care that has been operating in its cur-
rent form for more than 20 years.
Outcomes
The primary outcomes measured were frailty and mobility.
Frailty was assessed using the CHS definition of the frailty
syndrome [1]. See Additional file 1 for details of frailty
assessment criteria. Mobility was measured using the
SPPB [7], which assesses the ability to stand (for 10 s) with
the feet together in the side-by-side, semi-tandem and tan-
dem positions; time to walk 4 meters; and time to rise
from a chair and return to the seated position five times.
The SPPB score and the lower extremity continuous sum-
mary performance score were calculated [15].
Secondary outcomes included hospitalizations and
admissions to nursing care facilities that were reported
on monthly calendars and confirmed from either hospi-
tal records or the relevant facility; disability was mea-
sured with the Barthel Index [16], and health-related
quality of life measured by the EuroQol-5D (EQ-5D)
[17]. Psychological status was assessed using the Geria-
tric Depression Scale (short form) [13] and deaths were
recorded and verified by hospital records.
We initially chose the Timed Up and Go measure as a
co-primary outcome and included this on the Clinical
Trials Registry. However, early in the study we recog-
nized that it was not feasible to collect data for this out-
come and hence determined that the SPPB and Frailty
would be the co-primary outcome measures. These are
the co-primary outcomes recorded in the study protocol
paper [8].
The data were collected in the participants’ homes by
experienced research nurses trained specifically for the
trial. Training in the assessment tools was provided, and
joint sessions conducted to standardize the administra-
tion of the assessment tools, ensuring consistent inter-
pretation of the data recorded. Inter-rater reliability
checks were conducted at commencement and mid-way
through the trial.
The study aimed to recruit approximately 230 partici-
pants, to detect a clinically and statistically significant
15% difference in mobility as assessed by the lower extre-
mity continuous summary performance score between
the two groups (power = 80%, P = 0.05, dropouts = 15%,
non-compliance = 15%, standard deviation (SD) = 0.7).
A permuted block randomization approach was used
to achieve balanced treatment allocation. There were
two strata (frail with three CHS frailty criteria and very
frail with four or five CHS frailty criteria). A random
number sequence was generated for the order of treat-
ment allocation within the blocks using SPSS v15 RV.
UNIFORM function (SPSS, Inc., Chicago, IL, USA).
Block sizes of four and six were used and these blocks
were randomly arranged within blocks of ten.
Project personnel not involved in assessing partici-
pants or in providing the intervention managed the ran-
domized group allocation. The treatment allocation
tables for both strata were stored centrally off site.
Staff members performing the outcome assessment and
data analysis were masked to group allocation. It was not
possible to blind participants and staff administering the
interventions to group allocation. The number of partici-
pants inadvertently unblinding the outcome assessors
was recorded.
Harms
Adverse events were monitored and recorded by the
treating clinicians. Deaths were monitored by the study
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statistician. A data monitoring procedure was imple-
mented but, after consultation with the independent
epidemiologist monitoring the study, interim analyses
were not performed because of the limited number of
adverse events.
Statistical analysis
The study design assessed study participants at baseline,
at 3 months, and at 12 months after randomization.
Data were coded to permit blinding to group allocation
in the statistical analysis. The primary analyses were
undertaken in accordance with the intention-to-treat
principle. Frailty was treated as both a dichotomous
(that is, more than three CHS criteria met or not) and
continuous variable, and other study outcomes as con-
tinuous variables. The chi-square test was used for
frailty as a dichotomous variable, and linear regression
models with baseline values as a covariate were used for
continuous outcomes. We report between-group differ-
ences in percentages, or mean, with 95% confidence
intervals (CIs) at the 3- and 12-month follow-ups. We
tested whether the pattern of changes in frailty and mobi-
lity were modified by frailty severity at baseline, by includ-
ing an interaction term of study groups with frailty
severity at baseline in the regression analyses. Secondary
analyses were also carried out to explore the effect of dif-
ferent rates of adherence (as a category variable: <25%,
25% to 49%, 50% to 74% and ≥75%) on the outcomes in
the intervention group at the 12-month follow-up. The
Cox regression model was used to assess time to admis-
sion for those permanently admitted to aged care facilities.
Results
Characteristics of the study population
Participant flow is shown in Figure 1. Of the eligible
people approached, 75% (241 out of 322) agreed to par-
ticipate in the trial. Recruitment commenced in January
2008 and concluded in April 2010. Follow-up concluded
in June 2011.
Participant characteristics are shown in Table 1.
Women constituted 68% of participants, and the mean
age was 83.3 years. The groups were well matched at
baseline except that the control group had a slightly bet-
ter SPPB mean score.
At 3 months, follow-up data from 109 out of 120 of the
intervention group and 117 out of 121 of the control
group were available for analysis (Figure 1). At 12 months,
the availability of these follow-up data was 107 out of 120
and 109 out of 121 respectively. The follow-up attrition
rate was 10.4%, with 22 of the 25 losses due to death.
Interventions:The intervention and control treatments
were implemented as planned. Adherence was 0% for 16
participants (13%), including three people who died
before the intervention could commence. The median
adherence overall was in the category of 26% to 50%.
There was a median of 10 face-to-face sessions with a
physiotherapist for each participant in the intervention
group, including a median of eight sessions to teach the
WEBB program. In addition, there was a median of four
telephone calls to each participant and a median of four
telephone calls to other parties. The WEBB program
was delivered to 93% of intervention group participants.
A dietetic assessment and intervention was provided to
50% of participants (resulting in 29% being recom-
mended nutritional supplements). A medical specialist
consultation (with a geriatrician or rehabilitation physi-
cian) was arranged for 24% of participants. Referral to a
psychologist or psychiatrist was arranged for 3% of par-
ticipants. Further details of the intervention as imple-
mented are available from the authors on request.
Primary outcomes
There was a lower prevalence of frailty in the intervention
group compared with the control group at 12 months
(absolute difference 14.7%; 95% CI: 2.4%, 27.0%; P = 0.02;
number needed to treat = 6.8). Expressing frailty as a
number of the five frailty criteria showed similar results
(Table 2). Between-group differences in frailty were statis-
tically significant at 12 months but not at 3 months. At 12
months, the average reduction in the number of frailty cri-
teria was 0.80 (SD = 1.19) in the intervention group and
0.41 (SD = 1.02) in the control group (between-group dif-
ference 0.41; 95% CI, 0.14, 0.68; P < 0.01).
Mobility remained relatively stable in the intervention
group, whereas it declined substantially in the control
group. At 12 months, there was an average decline on the
12-point SPPB scale of 0.98 (SD = 2.30) in the control
group and an average increase of 0.52 points (SD = 2.47)
in the intervention group (between-group difference 1.44
points; 95% CI: 0.80, 2.07; P < 0.001). A similar result was
seen in mobility when assessed using the lower extremity
continuous summary performance score (Table 2).
Secondary outcomes
There were no major differences between the groups
with respect to the secondary outcomes of the trial (see
Table 2). The number of deaths in the intervention
group was 12 (10.0%), with 10 in the control group
(8.26%) (P = 0.64). A large number of hospital admis-
sions occurred, (intervention 74, control 67) with no sig-
nificant differences between the groups (P = 0.32).
There were similar numbers of permanent admissions
to nursing care facilities in both groups (intervention 16,
control 21) and, compared with the control group, the
hazard ratio of time to admission for the intervention
group was 0.69 (95% CI: 0.35, 1.33; P = 0.27).
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Changes in the individual components of the frailty
phenotype and the SPPB are summarized in Tables 3
and 4. We performed analyses based on adherence to
the intervention (see Table 5). Table 5 shows that higher
adherence was strongly associated with improved out-
comes, in particular the primary outcomes.
A number of participants (169 out of 241, 70%) inadver-
tently disclosed their treatment status to the assessors.
At the 12-month follow-up, disclosure of treatment status
occurred in 51% of cases. We analyzed SPPB scores by
whether the rater was unblinded or not, and there was no
significant difference in the scores (data not shown).
Harms
No major adverse events specifically attributable to the
intervention were evident. Two participants experienced
Assessed for eligibility (n=385) 
Excluded (n=144) 
♦ Not meeting inclusion criteria (n=63) 
♦ Declined to participate (n=81) 
 
Analysed at 3 months (n=109) 
Analysed at 12 months (n=107) 
At 3 months 
Lost to follow-up (n=11; 6 died, 1 withdrew, 3 
declined interview, 1 not interviewed).  
 
At 12 months  
Lost to follow-up (n=13; 12 died, 1 withdrew).  
 
Allocated to intervention (n=120) 
♦ Received allocated intervention (n=116) 
♦ Did not receive allocated intervention (n=4;  
3 died before any contact, 1 withdrew) 
At 3 months  
Lost to follow-up (n=4; 1 died, 2 withdrew, 1 
not interviewed) 
 
At 12 months 
Lost to follow-up (n=12; 10 died, 2 withdrew) 
 
Allocated to control group (n=121) 
♦ Received allocated control intervention (n=121)    
♦ Did not receive allocated control intervention  
 (n=0, not applicable)  
Analysed at 3 months (n=117) 











Figure 1 Eligibility, randomization and follow-up.
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back pain that met the adverse event criterion reported
in a previous study [18] and required modification of
their exercise program.
Discussion
The intervention reduced frailty and improved mobility
in older people who met the CHS frailty criteria. The
improvement in these primary outcomes contrasts with
the non-statistically significant changes in the secondary
outcomes. The lack of changes in secondary outcomes
may relate to limited power to detect changes using these
measures (see Table 5). However, the intervention
resulted in a reduction in mobility-related disability [19].
The benefit of the intervention was not evident at 3-
month follow-up and became apparent only at 12 months.
This indicates that an intervention treating frailty needs to
be prolonged. The analyses show participants who had
higher levels of adherence to the intervention had much
greater effects after adjusting for possible confounders.
We acknowledge that such analyses need to be interpreted
with caution [20].
In the months before participating in the study, 73% of
the participants had been hospitalized. A likely explanation
for the initial improvement in frailty in both the interven-
tion and control groups (25% of control participants
became non-frail by the 3-month follow-up) is that these
participants were still recovering from illness. After
3 months, the frailty and mobility status of the interven-
tion group was relatively stable whereas that of the control
group had deteriorated.
Strengths and limitations of study
The trial was completed in accordance with the published
protocol. It was a pragmatic randomized trial that
included participants meeting a widely accepted definition
of frailty and had few exclusion criteria. In keeping with
studies of this type, it was not possible to blind partici-
pants and treating clinicians to the intervention. Outcome







Male (%) 39 (33%) 39 (32%) 0.96
Age (year) 83.4 ±5.81 83.2 ±5.91 0.80
Lives alone (%) 60 (50%) 51 (42%) 0.22
Number of frailty criteria presentb (%) 0.84
Three 77 (64%) 79 (65%)
Four 33 (28%) 30 (25%)
Five 10 (8%) 12 (10%)
Weight 68.5 (15.7) 69.3 (17.3) 0.70
Exhaustion (%) 77 (64%) 76 (63%) 0.83
Grip strength (kg) 15.8 (7.2) 15.3 (7.2) 0.70
Gait speed (m/s) 0.48 (0.18) 0.50 (0.17) 0.32
Low physical activity (%) 73 (61%) 83 (69%) 0.21
Frailty, mean Cardiovascular Health Study score
Health status
3.44 (0.65) 3.45 (0.67) 0.96
Coexisting conditionsc 5.87 ±2.33 5.75 ±2.24 0.70
Body mass index (kg/m2) 26.1 ±5.91 26.4 ±6.04 0.67
Geriatric Depression Scaled,e 4.76 ±3.18 5.06 ±3.19 0.47
Mini Mental State Examinationd,e 26.6 ±2.59 25.9 ±3.14 0.07
Functioning
Disability, Barthel Indexe 93.9 ±11.1 92.5 ±14.3 0.40
Mobility, Short Physical Performance Batterye 5.21 ±1.89 5.74 ±2.12 0.04
Mobility, lower extremity continuous summary performance scoree 1.74 ±0.43 1.86 ±0.45 0.05
Health-related quality of life, EuroQol-5De 7.67 ±1.47 7.83 ±1.50 0.39
Health-related quality of life, EuroQol-5D VASe 58.2 ±15.8 57.9 ±18.4 0.90
Data presented as number (%) or mean ±standard deviation. aP-values were derived from the chi-square test or analysis of variance. bFrailty phenotype as
specified using Cardiovascular Health Study criteria. cSelf-reported, doctor-diagnosed medical conditions. dMissing data for Geriatric Depression Scale (n = 1), Mini
Mental Status Examination (n = 2). eThe Geriatric Depression Scale (short form) has scores between 0 and 15 with a higher score indicating more depressive
symptoms. For the Mini Mental Status Examination, higher scores indicate higher cognitive function with a maximum score of 30. The Barthel Index has scores
between 0 and 100 with higher scores indicating better basic activities of daily living functioning. The Short Physical Performance Battery [7] has scores between
0 and 12, and the lower extremity continuous summary performance [15] scale has scores between 0 and 2.71; in both, better mobility function is indicated by a
higher score. The EQ-5D has scores between 5 and 15 with higher scores indicating worse health-related quality of life. The EQ-5D VAS has scores between 0
and 100 with higher scores indicating better health-related quality of life. VAS: visual analog scale.
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assessors were blinded but many participants inadvertently
disclosed their treatment status. The components of the
frailty definition are partly self-reported and partly perfor-
mance based, but the co-primary outcome (the SPPB) is a
performance-based measure that should reduce observer
bias.
The lack of a control group providing a sham interven-
tion could be seen as a limitation and our trial does not
tell us whether the nature of the contact with the staff pro-
viding the intervention was important. It is unlikely that
such contacts could have specific effects on frailty and
mobility, but could have had an effect on mood that may
influence the exhaustion criterion in the CHS frailty phe-
notype [21]. However, we consider our trial to be com-
parative effectiveness research in which we are comparing
the two options of usual care versus potential care through
this program.
Adverse events were minor and responded to a change
in the prescribed exercise intervention. Skilled phy-
siotherapists tailored and delivered the intervention.
Dropouts were not due to adverse events but were
rather related to participants’ beliefs or to major changes
in their health conditions.
Generalizability:The study was conducted in a relatively
affluent country with well-developed health and care ser-
vices for older people. It used a specific clinical team
with considerable experience and knowledge of the
locally available aged care services. It should be feasible
to generalize the intervention to other situations with
similar health and care services. It is a moderate intensity
Table 2 Effects of the intervention on primary and secondary outcomes, intention-to-treat analyses
Intervention group Control group Percentage difference between groups or coefficienta Pb
Primary outcomes
Frailtyc
3 months (number (%)) 69 out of 108 (64%) 88 out of 117 (75%) -11.3% (-23.3% to 0.7%) 0.07
12 months (number (%)) 66 out of 107 (62%) 81 out of 106 (76%) -14.7% (-27.0% to -2.4%) 0.02
Change from 0 to 3 months 108, 0.56 ±1.10 117, 0.39 ±0.92 -0.18 (-0.43 to 0.08) 0.17
Change from 0 to 12 months 107, 0.80 ±1.19 106, 0.41 ±1.02 -0.41 (-0.68 to -0.14) <0.01
Mobility, Short Physical Performance Batteryc
3-month mean
12-month mean
Change from 0 to 3 months









0.05 (-0.42 to 0.51)
1.44 (0.80 to 2.07)
0.85
<0.001
Mobility, lower extremity continuous summary performance scorec
3-month mean
12-month mean
Change from 0 to 3 months









-0.00 (-0.12 to 0.11)







Change from 0 to 3 months









-0.68 (-3.05 to 1.68)






Change from 0 to 3 months









0.22 (-0.37 to 0.82)






Change from 0 to 3 months









0.04 (-3.93 to 4.00)
0.30 (-4.59 to 5.18)
0.99
0.91
Data presented as number, mean, ±standard deviation, unless otherwise stated. aCoefficient from a linear regression model with follow-up values as a dependent
variable and baseline values as a covariate. bP values, which were derived from chi-square test or linear regression models with baseline values as a covariate, are
for the differences in rate or mean between intervention and control group. cThe Geriatric Depression Scale (short form) has scores between 0 and 15 with a
higher score indicating more depressive symptoms. For the Mini Mental Status Examination, higher scores indicate higher cognitive function with a maximum
score of 30. The Barthel Index has scores between 0 and 100 with higher scores indicating better basic activities of daily living functioning. The Short Physical
Performance Battery [7] has scores between 0 and 12, and the lower extremity continuous summary performance [15] scale has scores between 0 and 2.71; in
both, better mobility function is indicated by a higher score. The EQ-5D (health-related quality of life) has scores between 5 and 15 with higher scores indicating
worse health-related quality of life. The EQ-5D VAS has scores between 0 and 100 with higher scores indicating better health-related quality of life. VAS: visual
analog scale.
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intervention that could be provided as a program
through an aged care health service. The intervention
costs about a quarter of the amount of the program cur-
rently administered by the Australian government,
designed to assist a similar group of older people in the
transition from hospital to home or nursing care facility
[22].
Comparison with other studies
Trials involving older people with reduced functioning,
labeled as ‘frail’, have shown variable improvements in
disability and its components. A recent systematic review
of exercise interventions in frail populations concluded
that multicomponent exercise treatments for frail people
are likely to be effective if undertaken on a regular basis
over a prolonged period [6]. The geriatric evaluation and
management literature has shown mixed effects with
respect to overall benefit. This study adds to previous
research by demonstrating that it is possible to identify
frail older people for inclusion in a randomized trial, and
that intervention can reduce the degree of frailty and
improve mobility outcomes in this population.
In the group studied, it is difficult to disentangle ‘frailty’
from ‘disability’ because these two states coexisted in
almost all participants. Although improvement in frailty
was seen there was also improvement in mobility disability.





Percentage difference between groups or coefficienta Pb
Frailty criteria
Weight (kg)
Change from 0 to 3 months 224 0.40 ±3.72 0.92 ±3.59 0.51 (-0.45 to 1.48) 0.29
Change from 0 to 12 months 210 0.72 ±5.98 1.48 ±5.09 0.78 (-0.72 to 2.28) 0.31
Exhaustion
Rate at 3 months (number (%)) 225 47 (44%) 46 (39%) 4.2% (-8.7% to 17.1%) 0.52
Rate at 12 months (number (%)) 213 29 (27%) 35 (33%) -5.9% (-18.2% to 6.4%) 0.35
Grip strength (kg)
Change from 0 to 3 months 225 0.78 ±3.56 1.02 ±4.93 0.50 (-0.55 to 1.54) 0.35
Change from 0 to 12 months 213 0.93 ±4.62 1.88 ±5.75 1.18 (-0.13 to 2.49) 0.08
Gait speed (meter/second)
Change from 0 to 3 months 225 -0.006 ±0.155 -0.007 ±0.169 -0.004 (-0.046 to 0.039) 0.87
Change from 0 to 12 months 213 -0.049 ±0.183 0.019 ±0.230 0.068 (0.012 to 0.123) 0.02
Low physical activity
Rate at 3 months - No. (%) 225 59 (55%) 74 (63%) -8.6% (-21.4% to 4.2%) 0.19
Rate at 12 months - No. (%) 213 67 (63%) 80 (76%) -12.9% (-25.2% to -0.6%) 0.04
Data presented as mean, ±standard deviation, unless otherwise stated. aCoefficient from a linear regression model with follow-up values as a dependent variable
and baseline values as a covariate. bP values, which were derived from linear regression models with baseline values as a covariate, are for the differences in
mean between intervention and control group. Percentages are calculated based on number of participants available for follow-up.







Short Physical Performance Battery criteria
Balance score
Change from 0 to 3 months 223 0.19 ±1.13 0.21 ± 1.02 -0.06 (-0.32 to 0.20) 0.63
Change from 0 to 12 months 215 -0.11 ±1.24 0.59 ±1.25 0.63 (0.32 to 0.95) <0.001
Measured walks score
Change from 0 to 3 months 223 -0.07 ±0.80 -0.08 ±0.80 -0.02 (-0.22 to 0.18) 0.82
Change from 0 to 12 months 215 -0.27 ±0.90 0.08 ±0.96 0.35 (0.10 to 0.59) 0.006
Chair stands score
Change from 0 to 3 months 223 -0.26 ±0.94 -0.12 ±0.87 0.04 (-0.18 to 0.27) 0.72
Change from 0 to 12 months 215 -0.14 ±1.22 0.31 ±0.98 0.33 (0.07 to 0.59) 0.01
Data given as mean, ±standard deviation. aCoefficient from a linear regression model with follow-up values as a dependent variable and baseline values as a
covariate.bP values, which were derived from linear regression models with baseline values as a covariate, are for the differences in mean between intervention
and control group.
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The changes in frailty and mobility are similar in magni-
tude and represent medium effect sizes. In this study,
changes in frailty and mobility appear closely linked. The
measure of activities of daily living disability that was used,
the Barthel Index, was close to its maximum and ceiling
effects may have limited the ability to detect changes in dis-
ability as defined by this measure.
Conclusions
This study has shown that treating frailty in older people is
a realistic therapeutic goal. Ideally a multicenter study with
a larger sample size should be conducted to confirm and
extend the findings of this study. Future studies should
also consider follow-up beyond the end of the intervention
period.
Frailty and mobility disability can be successfully trea-
ted using an interdisciplinary multifaceted treatment
program.
Additional material
Additional file 1: Frailty outcome measure. Definition of the frailty
components, adapted from Cardiovascular Health Study Criteria [1]
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